Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial-Reference-Cited by-同舟云学术

Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial

Published:2021-02 Issue:5 Volume:77 Page:511-525
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Guzik Tomasz J.,Ramasundarahettige Chinthanie,Pogosova Nana,Lopez-Jaramillo Patricio,Dyal Leanne,Berkowitz Scott D.,Muehlhofer Eva,Bhatt Deepak L.,Fox Keith A.A.,Yusuf Salim,Eikelboom John W.

Funder

Bayer

European Research Council

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial;Connolly;Lancet,2018

2. Rivaroxaban with or without aspirin in stable cardiovascular disease;Eikelboom;N Engl J Med,2017

3. Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?;Fox;Eur Heart J,2019

4. Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease;Cowie;Cardiovasc Res,2020

5. Rationale, design and baseline characteristics of participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial;Bosch;Can J Cardiol,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct oral anticoagulants and the risk of adverse clinical outcomes among patients with different body weight categories: a large hospital-based study;European Journal of Clinical Pharmacology;2023-11-18

2. Low dose rivaroxaban for the management of atherosclerotic cardiovascular disease;Journal of Thrombosis and Thrombolysis;2023-05-06

3. EvidenceMap: a three-level knowledge representation for medical evidence computation and comprehension;Journal of the American Medical Informatics Association;2023-03-15

4. A Real-World Exploration into Clinical Outcomes of Direct Oral Anticoagulant Dosing Regimens in Morbidly Obese Patients Using Data-Driven Approaches;American Journal of Cardiovascular Drugs;2023-03-06

5. Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index;JACC: Cardiovascular Interventions;2022-10